- Report
- October 2023
- 110 Pages
Global
From €4188EUR$4,500USD£3,503GBP
- Report
- July 2023
- 119 Pages
Global
From €4188EUR$4,500USD£3,503GBP
- Report
- January 2023
- 119 Pages
Global
From €4188EUR$4,500USD£3,503GBP
- Report
- June 2025
- 83 Pages
United States
From €3257EUR$3,500USD£2,724GBP
- Report
- March 2025
- 135 Pages
Asia Pacific
From €3723EUR$4,000USD£3,113GBP
- Report
- October 2024
- 180 Pages
Global
From €4188EUR$4,500USD£3,503GBP
- Report
- June 2023
- 116 Pages
Global
From €4188EUR$4,500USD£3,503GBP
- Report
- June 2025
- 571 Pages
Global
From €4179EUR$4,490USD£3,495GBP
- Report
- September 2024
- 330 Pages
Global
From €4653EUR$5,000USD£3,892GBP
- Report
- May 2025
- 85 Pages
United States
From €3257EUR$3,500USD£2,724GBP
- Report
- November 2024
- 180 Pages
Global
From €4188EUR$4,500USD£3,503GBP
- Report
- February 2024
- 180 Pages
Global
From €4188EUR$4,500USD£3,503GBP
- Report
- February 2024
- 172 Pages
Global
From €4188EUR$4,500USD£3,503GBP
- Report
- October 2023
- 130 Pages
Europe
From €3723EUR$4,000USD£3,113GBP
- Report
- October 2023
- 145 Pages
Global
From €2932EUR$3,150USD£2,452GBP
- Report
- October 2023
- 145 Pages
Global
From €2932EUR$3,150USD£2,452GBP
- Report
- August 2025
- 194 Pages
Global
From €3299EUR$3,545USD£2,759GBP
€3666EUR$3,939USD£3,066GBP
- Report
- August 2025
- 192 Pages
Global
From €3299EUR$3,545USD£2,759GBP
€3666EUR$3,939USD£3,066GBP
- Report
- August 2025
- 194 Pages
Global
From €3299EUR$3,545USD£2,759GBP
€3666EUR$3,939USD£3,066GBP
- Report
- August 2024
- 150 Pages
Global
From €3490EUR$3,750USD£2,919GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more